Sign inJoin waitlistJoin the waitlist

Andres Yarur

Associate Professor of Medicine · Cedars-Sinai

Credentials: · · · · · ·

History

Cedars-Sinai
Present

Gastroenterology
University of Miami/Jackson Health System
2009–2012
Internal Medicine
2006–2009
Doctor of Medicine
2002–2006

Research

Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies
The Lancet · 2023 · 318 citations
Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease
Alimentary Pharmacology & Therapeutics · 2017 · First of 11 authors · 255 citations
Inflammatory bowel disease is associated with an increased incidence of cardiovascular events
The American Journal of Gastroenterology · 2011 · First of 6 authors · 218 citations

Parakkal Deepak
23 papers
Maria Abreu
21 papers
MD
Marla Dubinsky
17 papers
David Rubin
16 papers
Daniel Sussman
11 papers
Poonam Beniwal-Patel
11 papers
Amar Deshpande
10 papers
Ryan Ungaro
9 papers
Bruce Sands
8 papers
Jean-Frederic Colombel
8 papers
Joel Pekow
8 papers
AJ
Amanda Johnson
7 papers

Clinical trials

Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
Principal investigator · Recruiting · Phase 2
Washington University School of Medicine
2025–2028
Vedolizumab Monotherapy Vs Combination Therapy With Tacrolimus in UC
Principal investigator · Terminated · Phase 3
Medical College of Wisconsin
2017–2019
Tirzepatide for Ileal Pouch-anal Anastomosis (IPAA) and Chronic High Bowel Frequency (I8F-NS-X008)
Site PI · Not yet recruiting · Phase 4
University of North Carolina, Chapel Hill
2026–2027
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2025–2028